Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Sanofi vs Lanzhou Meningococcal A+C Vaccines in Chinese Children
NCT01430611Phase 4Completed
- Sponsor
- Sanofi
- Start
- Aug 2011
- Primary completion
- Aug 2012
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Meningo A + C in meningococcal disease, sponsored by Sanofi. Started Aug 2011; status: completed.
02
Drugs
Meningo A + C
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on NCT01430611.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01430611.